BRCA1/2 testing: therapeutic implications for breast cancer management

por Tung, Nadine M., Garber, Judy E.
Publicado 2018

Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers

por Song, Yun, Barry, William T., Seah, Davinia S., Tung, Nadine M., Garber, Judy E., Lin, Nancy U.
Publicado 2019

Li-Fraumeni syndrome: not a straightforward diagnosis anymore—the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism,...

por Batalini, Felipe, Peacock, Ellie G., Stobie, Lindsey, Robertson, Alison, Garber, Judy, Weitzel, Jeffrey N., Tung, Nadine M.
Publicado 2019

Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen rec...

por Burga, Laura N, Hu, Hai, Juvekar, Ashish, Tung, Nadine M, Troyan, Susan L, Hofstatter, Erin W, Wulf, Gerburg M
Publicado 2011

Contemporary multidisciplinary treatment of pregnancy-associated breast cancer

por Meisel, Jane L, Economy, Katherine E, Calvillo, Katherina Zabicki, Schapira, Lydia, Tung, Nadine M, Gelber, Shari, Kereakoglow, Sandra, Partridge, Ann H, Mayer, Erica L
Publicado 2013

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study

por Iqbal, Javaid, Nussenzweig, Andre, Lubinski, Jan, Byrski, Tomasz, Eisen, Andrea, Bordeleau, Louise, Tung, Nadine M, Manoukian, Siranoush, Phelan, Catherine M, Sun, Ping, Narod, Steven A
Publicado 2016

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer

por Desai, Neelam V., Barrows, Elizabeth D., Nielsen, Sarah M., Hatchell, Kathryn E., Anderson, Michael J., Haverfield, Eden V., Herrera, Blanca, Esplin, Edward D., Lucassen, Anneke, Tung, Nadine M., Isaacs, Claudine
Publicado 2023

Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PAL...

por Batalini, Felipe, Madison, Russell W., Sokol, Ethan S., Jin, Dexter X., Chen, Kuei-Ting, Decker, Brennan, Pavlick, Dean C., Frampton, Garrett M., Wulf, Gerburg M., Garber, Judy E., Oxnard, Geoffrey, Schrock, Alexa B., Tung, Nadine M.
Publicado 2023

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies

por Morganti, Stefania, Bychkovsky, Brittany L, Poorvu, Philip D, Garrido-Castro, Ana C, Weiss, Anna, Block, Caroline C, Partridge, Ann H, Curigliano, Giuseppe, Tung, Nadine M, Lin, Nancy U, Garber, Judy E, Tolaney, Sara M, Lynce, Filipa
Publicado 2023

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

por Metcalfe, Kelly, Eisen, Andrea, Senter, Leigha, Armel, Susan, Bordeleau, Louise, Meschino, Wendy S., Pal, Tuya, Lynch, Henry T., Tung, Nadine M., Kwong, Ava, Ainsworth, Peter, Karlan, Beth, Moller, Pal, Eng, Charis, Weitzel, Jeffrey N., Sun, Ping, Lubinski, Jan, Narod, Steven A.
Publicado 2019

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

por Batalini, Felipe, Gulhan, Doga C., Mao, Victor, Tran, Antuan, Polak, Madeline, Xiong, Niya, Tayob, Nabihah, Tung, Nadine M., Winer, Eric P., Mayer, Erica L., Knappskog, Stian, Lønning, Per E., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A., Solit, David B., Won, Helen, Eikesdal, Hans P., Park, Peter J., Wulf, Gerburg M.
Publicado 2022

A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer

por Waks, Adrienne G., Desai, Neelam V., Li, Tianyu, Poorvu, Philip D., Partridge, Ann H., Sinclair, Natalie, Spring, Laura M., Faggen, Meredith, Constantine, Michael, Metzger, Otto, Alberti, Jillian, Deane, Julia, Rosenberg, Shoshana M., Frank, Elizabeth, Tolaney, Sara M., Krop, Ian E., Tung, Nadine M., Tayob, Nabihah, King, Tari A., Mittendorf, Elizabeth A., Winer, Eric P.
Publicado 2022

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

por Cruz, Cristina, Llop-Guevara, Alba, Garber, Judy E., Arun, Banu K., Pérez Fidalgo, José A., Lluch, Ana, Telli, Melinda L., Fernández, Cristian, Kahatt, Carmen, Galmarini, Carlos M., Soto-Matos, Arturo, Alfaro, Vicente, Pérez de la Haza, Aitor, Domchek, Susan M., Antolin, Silvia, Vahdat, Linda, Tung, Nadine M., Lopez, Rafael, Arribas, Joaquín, Vivancos, Ana, Baselga, José, Serra, Violeta, Balmaña, Judith, Isakoff, Steven J.
Publicado 2018

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

por Lenz, Lauren, Neff, Chris, Solimeno, Cara, Cogan, Elizabeth S., Abramson, Vandana G., Boughey, Judy C., Falkson, Carla, Goetz, Matthew P., Ford, James M., Gradishar, William J., Jankowitz, Rachel C., Kaklamani, Virginia G., Marcom, P. Kelly, Richardson, Andrea L., Storniolo, Anna Maria, Tung, Nadine M., Vinayak, Shaveta, Hodgson, Darren R., Lai, Zhongwu, Dearden, Simon, Hennessy, Bryan T., Mayer, Erica L., Mills, Gordon B., Slavin, Thomas P., Gutin, Alexander, Connolly, Roisin M., Telli, Melinda L., Stearns, Vered, Lanchbury, Jerry S., Timms, Kirsten M.
Publicado 2023